Physician profile
Robert Thorsness
NPI 1588989164
$4,030.65
in general payments reported to CMS, 2019-2025
24 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $871 · 2020: $199 · 2021: $277 · 2022: $183 · 2023: $2,190 · 2024: $186 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,322 · Food and Beverage: $1,178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,321.60 |
| Food and Beverage | $1,178.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,255.03 | 2019-2025 | Blueprint Patient Specific Instrumentation, Gamma, Inspace |
| Medwest Associates | $594.00 | 2019 | |
| Depuy Synthes Sales INC. | $272.90 | 2019-2021 | |
| Smith+Nephew, INC. | $179.93 | 2020-2022 | |
| Anika Therapeutics, INC. | $141.49 | 2023 | Ovomotion, Revomotion |
| Encore Medical, LP | $121.36 | 2019 | |
| Orthofix Medical, INC. | $72.68 | 2019-2025 | Physio-Stim |
| Ferring Pharmaceuticals INC. | $69.45 | 2023-2025 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $41.53 | 2019-2022 | |
| Deroyal Industries, INC. | $30.41 | 2024 | Flex Npwt Single Use System, Deroyal Universal Recovery Post-Op Knee Brace |
| Zimmer Biomet Holdings, INC. | $30.11 | 2023 | Quattro |
| Heron Therapeutics, INC. | $27.58 | 2024 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $22.74 | 2025 | |
| Bioventus LLC | $20.49 | 2019 | |
| Endo Pharmaceuticals INC. | $19.51 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19.07 | 2021 | |
| Catalyst Orthoscience | $18.77 | 2020 | |
| Ermi LLC | $16.99 | 2025 | |
| Linvatec Corporation | $16.03 | 2024 | Biobrace 23mm |
| Ethicon US, LLC | $13.42 | 2022 | |
| Horizon Therapeutics Plc | $13.28 | 2022 | |
| Avanos Medical | $12.07 | 2019 | |
| Arthrosurface Incorporated | $11.00 | 2019 | |
| Assertio Therapeutics, INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Thorsness listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.